Clonidine and Adempas drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Clonidine (clonidine) and Adempas (riociguat). Common drug interactions include pulmonary arterial hypertension among females and infusion site pain among males.
The phase IV clinical study analyzes what interactions people have when they take Clonidine and Adempas. It is created by eHealthMe based on reports of 132 people who take the same drugs from the FDA, and is updated regularly.
What is Clonidine?
Clonidine has active ingredients of clonidine. It is often used in high blood pressure. eHealthMe is studying from 65,645 Clonidine users. Check the latest studies of Clonidine.
What is Adempas?
Adempas has active ingredients of riociguat. eHealthMe is studying from 29,741 Adempas users. Check the latest studies of Adempas.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
132 people who take Clonidine and Adempas together, and have interactions are studied.
What are the common drug interactions of Clonidine and Adempas, by gender? *
What are the common drug interactions of Clonidine and Adempas, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Clonidine and Adempas?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Clonidine and Adempas:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Clonidine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Adempas:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Clonidine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Adempas and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on clonidine and riociguat (the active ingredients of Clonidine and Adempas, respectively), and Clonidine and Adempas (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Rebif and Azithromycin - a second ago
- Could Claritin cause Skin Tightness? - 5 seconds ago
- Could Enalapril Maleate cause Polyp? - 5 seconds ago
- Could Oxazepam cause Restless Leg Syndrome? - 7 seconds ago
- Could Calcium Carbonate cause Dizziness? - 12 seconds ago
- Drug interactions of Plendil and Tracleer - 14 seconds ago
- Could Metformin cause Epiglottitis? - 21 seconds ago
- Could Buprenorphine cause Sneezing? - 21 seconds ago
- Drug interactions of Pantoprazole and Zipsor - 21 seconds ago
- Could Mobic cause Drug Intolerance? - 25 seconds ago